Donna Palumbo

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Psychological testing in adolescent medicine
    Donna Palumbo
    School of Medicine and Dentistry, University of Rochester Medical Center, and Strong Neurology ADHD Program, Monroe Community Hospital, 919 Westfall Road, Bldg C Suite 220, Rochester, NY 14618, USA
    Adolesc Med Clin 17:147-64. 2006
  2. ncbi Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy
    Donna Palumbo
    Strong Neurology ADHD Medical Center, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642 8673, USA
    J Child Adolesc Psychopharmacol 14:185-94. 2004
  3. ncbi Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy
    Marc B Lande
    Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    J Pediatr 157:114-9. 2010
  4. ncbi Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study
    Gary J Myers
    Department of Neurology, National Institute for Child Health and Development, National Institutes of Health, Department of Health and Human Services, Bethesda, USA
    Lancet 361:1686-92. 2003
  5. ncbi Efficacy and tolerability of low-dose donepezil in schizophrenia
    Steven K Erickson
    University of Rochester Medical Center, Department of Psychiatry, New York 14642, USA
    Clin Neuropharmacol 28:179-84. 2005
  6. ncbi Methylmercury and neurodevelopment: longitudinal analysis of the Seychelles child development cohort
    Philip W Davidson
    The Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, 14642, USA
    Neurotoxicol Teratol 28:529-35. 2006
  7. ncbi Parental assessments of internalizing and externalizing behavior and executive function in children with primary hypertension
    Marc B Lande
    Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA
    J Pediatr 154:207-12. 2009
  8. ncbi ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study
    Timothy Wilens
    Clinical Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital and Harvard Medical School, 15 Parkman Street, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 42:424-33. 2003
  9. ncbi Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis
    W Burleson Daviss
    University of Texas Health Science Center at San Antonio, TX, USA
    J Am Acad Child Adolesc Psychiatry 47:189-98. 2008
  10. ncbi HIV-associated cognitive impairment before and after the advent of combination therapy
    Ned Sacktor
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    J Neurovirol 8:136-42. 2002

Detail Information

Publications11

  1. ncbi Psychological testing in adolescent medicine
    Donna Palumbo
    School of Medicine and Dentistry, University of Rochester Medical Center, and Strong Neurology ADHD Program, Monroe Community Hospital, 919 Westfall Road, Bldg C Suite 220, Rochester, NY 14618, USA
    Adolesc Med Clin 17:147-64. 2006
    ..Psychological assessment can be invaluable in the early identification and intervention of learning, behavioral, and psychiatric difficulties in adolescents...
  2. ncbi Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy
    Donna Palumbo
    Strong Neurology ADHD Medical Center, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642 8673, USA
    J Child Adolesc Psychopharmacol 14:185-94. 2004
    ....
  3. ncbi Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy
    Marc B Lande
    Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    J Pediatr 157:114-9. 2010
    ..To determine the change in parental ratings of executive function and behavior in children with primary hypertension after anti-hypertensive therapy...
  4. ncbi Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study
    Gary J Myers
    Department of Neurology, National Institute for Child Health and Development, National Institutes of Health, Department of Health and Human Services, Bethesda, USA
    Lancet 361:1686-92. 2003
    ..The most common form of prenatal exposure is maternal fish consumption, but whether such exposure harms the fetus is unknown. We aimed to identify adverse neurodevelopmental effects in a fish-consuming population...
  5. ncbi Efficacy and tolerability of low-dose donepezil in schizophrenia
    Steven K Erickson
    University of Rochester Medical Center, Department of Psychiatry, New York 14642, USA
    Clin Neuropharmacol 28:179-84. 2005
    ..These results suggest that donepezil may be helpful as adjunctive therapy for the treatment of psychiatric symptoms and cognitive impairment in a subgroup of schizophrenic patients...
  6. ncbi Methylmercury and neurodevelopment: longitudinal analysis of the Seychelles child development cohort
    Philip W Davidson
    The Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, 14642, USA
    Neurotoxicol Teratol 28:529-35. 2006
    ..These findings suggest that the associations observed between MeHg and developmental outcomes may vary with developmental stage...
  7. ncbi Parental assessments of internalizing and externalizing behavior and executive function in children with primary hypertension
    Marc B Lande
    Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA
    J Pediatr 154:207-12. 2009
    ..To determine the relations between hypertension and parental ratings of behavior and executive functions in children with primary hypertension and to examine the potential moderating influence of obesity...
  8. ncbi ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study
    Timothy Wilens
    Clinical Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital and Harvard Medical School, 15 Parkman Street, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 42:424-33. 2003
    ..This article reports an interim analysis of a 24-month study evaluating the 12-month tolerability and effectiveness of a once-daily OROS formulation of methylphenidate (OROS MPH) in children with ADHD...
  9. ncbi Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis
    W Burleson Daviss
    University of Texas Health Science Center at San Antonio, TX, USA
    J Am Acad Child Adolesc Psychiatry 47:189-98. 2008
    ..To examine the safety and tolerability of clonidine used alone or with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD)...
  10. ncbi HIV-associated cognitive impairment before and after the advent of combination therapy
    Ned Sacktor
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    J Neurovirol 8:136-42. 2002
    ..Even though HAART has reduced the incidence of HIV dementia, HIV-associated cognitive impairment continues to be a major clinical problem among individuals with advanced infection...
  11. ncbi An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection
    Jeffrey J Sevigny
    Department of Neurology and Gertrude H Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Arch Neurol 64:97-102. 2007
    ..Several markers of immune activation have been identified as potential prognostic markers for human immunodeficiency virus (HIV)-associated morbidity and mortality, but the results from studies are conflicting...